Consonance Capital Management LP Adicet Bio, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.29 - $9.93 $6.45 Million - $10.2 Million
-1,025,405 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$9.19 - $15.93 $1.76 Million - $3.05 Million
-191,455 Reduced 15.73%
1,025,405 $10.6 Million
Q1 2021

May 17, 2021
BUY
$12.12 - $17.17 $14.7 Million - $20.9 Million
1,216,860 New
1,216,860 $15.9 Million

Others Institutions Holding ACET

# of Institutions
85
Shares Held
65.6M
Call Options Held
4.3K
Put Options Held
36.3K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $48M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email